OTC:BBLG Bone Biologics (BBLG) Stock Price, News & Analysis → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free BBLG Stock Alerts $1.85 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$1.80▼$1.9450-Day Range$1.52▼$3.6052-Week Range$1.46▼$72.00Volume24,924 shsAverage Volume96,184 shsMarket Capitalization$987,900.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Bone Biologics alerts: Email Address Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… About Bone Biologics Stock (OTC:BBLG)Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.Read More BBLG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBLG Stock News HeadlinesMay 2, 2024 | americanbankingnews.comBone Biologics (OTC:BBLG) Stock Price Up 7.6%March 4, 2024 | markets.businessinsider.comBone Biologics Announces Pricing Of $2 Mln Public OfferingMay 4, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.March 4, 2024 | msn.comBone Biologics rises 5% on $2M equity offeringMarch 1, 2024 | msn.comBone Biologics stock jumps after reporting progress with NB1 clinical programFebruary 22, 2024 | finance.yahoo.comBBLG Releases Annual Report Amid Continued Pursuit of Breakthrough TreatmentJanuary 11, 2024 | finance.yahoo.comBone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of DirectorsDecember 28, 2023 | msn.comWhat's Going On With Bone Biologics Corp Stock?May 4, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.December 20, 2023 | finance.yahoo.comBBLG Announces Split as Pursuit of Breakthrough Treatment ContinuesDecember 18, 2023 | msn.comBone Biologics to conduct 1-for-8 reverse stock splitDecember 18, 2023 | markets.businessinsider.comBone Biologics Authorised For 1-for-8 Reverse Stock SplitDecember 18, 2023 | finance.yahoo.comBone Biologics Announces 1-for-8 Reverse Stock SplitNovember 20, 2023 | msn.comWhy Bone Biologics Stock (BBLG) Is Falling SharplyNovember 20, 2023 | finance.yahoo.comBone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 17, 2023 | msn.comWhy Bone Biologics Stock (BBLG) Is Getting Obliterated FridayNovember 16, 2023 | finance.yahoo.comBone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 15, 2023 | finance.yahoo.comBBLG Offers Good Entry OpportunityNovember 14, 2023 | msn.comWhat Are Biologics?November 14, 2023 | morningstar.comBone Biologics Corp BBLGSeptember 26, 2023 | finance.yahoo.comBone Biologics Provides Scientific Update on NB1 Bone Graft DeviceSeptember 24, 2023 | abcnews.go.comRobin Roberts' sister reflects on sibling's upcoming wedding after lifesaving bone marrow donationSeptember 22, 2023 | bbc.co.ukBone brothSeptember 15, 2023 | finance.yahoo.comInsider Buying: CFO Deina Walsh Acquires 8,000 Shares of Bone Biologics Corp (BBLG)September 13, 2023 | finance.yahoo.comCEO Jeff Frelick Buys 9,500 Shares of Bone Biologics Corp (BBLG)August 23, 2023 | nypost.comMan killed roommate, and lived with body in closet for monthsAugust 17, 2023 | detroitnews.comTB death in Michigan linked to contaminated bone graft materialSee More Headlines Receive BBLG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTC:BBLG CUSIPN/A CIKN/A Webwww.bonebiologics.com Phone781-552-4452FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($49.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,490,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-123.44% Return on Assets-82.64% Debt Debt-to-Equity RatioN/A Current Ratio3.95 Quick Ratio3.95 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.82 per share Price / Book1.02Miscellaneous Outstanding Shares534,000Free Float2,886,000Market Cap$987,900.00 OptionableNot Optionable Beta0.18 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jeffrey Frelick (Age 58)CEO & President Comp: $325kMs. Deina H. Walsh (Age 60)Chief Financial Officer Comp: $212.5kDr. Shun'ichi KurodaCo-Founder & Member of Scientific Advisory BoardKey CompetitorsImmunoCellular TherapeuticsOTCMKTS:IMUCDRegenicinOTCMKTS:RGINAkandaNASDAQ:AKANAcorda TherapeuticsNASDAQ:ACORScinai ImmunotherapeuticsNASDAQ:SCNIView All Competitors BBLG Stock Analysis - Frequently Asked Questions How have BBLG shares performed in 2024? Bone Biologics' stock was trading at $4.52 at the beginning of the year. Since then, BBLG stock has decreased by 59.1% and is now trading at $1.85. View the best growth stocks for 2024 here. When did Bone Biologics' stock split? Shares of Bone Biologics reverse split on the morning of Wednesday, June 7th 2023. The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Bone Biologics? Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:BBLG) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
